Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Rare Disease Drug Development
  • Language: en
  • Pages: 418

Rare Disease Drug Development

This book provides a broad overview of rare disease drug development. It offers unique insights from various perspectives, including third-party capital providers, caregivers, patient advocacy groups, drug development professionals, marketing and commercial experts, and patients. A unique reference, the book begins with narratives on the many challenges faced by rare disease patient and their caregivers. Subsequent chapters underscore the critical, multidimensional role of patient advocacy groups and the novel approaches to related clinical trials, investment decisions, and the optimization of rare disease registries. The book addresses various rare disease drug development processes by disc...

Optimization of Pharmaceutical R&D Programs and Portfolios
  • Language: en
  • Pages: 204

Optimization of Pharmaceutical R&D Programs and Portfolios

  • Type: Book
  • -
  • Published: 2014-10-10
  • -
  • Publisher: Springer

Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of published literature is coming from the commercial side, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book there is a strong focus on impact of study design on PoS and ultimately on the value of portfolio. Design options that are discussed in different chapters are dose-selection strategies, adaptive design and enrichment. Some development strategies that are discussed are indication sequencing, optimal number of programs and optimal decision criteria. This book includes chapters written by authors with very br...

Muscular Dystrophy
  • Language: en
  • Pages: 206

Muscular Dystrophy

  • Type: Book
  • -
  • Published: 2015-07-16
  • -
  • Publisher: Springer

This practical and concise guide offers an overview of muscular dystrophy's complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.

The Textbook of Pharmaceutical Medicine
  • Language: en
  • Pages: 856

The Textbook of Pharmaceutical Medicine

The Textbook of Pharmaceutical Medicine is the standard reference for everyone working and learning in pharmaceutical medicine. It is a comprehensive resource covering the processes and practices by which medicines are developed, tested and approved, and the recognised text for the Diploma in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine. This fully revised Seventh Edition, which includes two new Editors, encompasses current developments within pharmaceutical medicine with new chapters on biological therapeutics, pharmacovigilance, vaccines, drugs for cancer, drug development in paediatrics and neonatalogy, the clinical trials directive, life cycle management of medicin...

Introduction to the Due Diligence Process
  • Language: en

Introduction to the Due Diligence Process

  • Type: Book
  • -
  • Published: 2010-03-01
  • -
  • Publisher: Unknown

Discussion of the due diligence process for product-based healthcare product investments.

Raising Healthy Fish III
  • Language: en
  • Pages: 100

Raising Healthy Fish III

None

Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
  • Language: en
  • Pages: 94

Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional

This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These apply particularly to evaluations that focus on outputs such as regulatory approval, or the commercial impact of product labeling on the sales forecast over a limited timeframe. The Brief also provides an overview of intellectual property assessment that can impact a product’s lifespan on the market due to patent protection itself (or loss of patent protection) or via regulatory exclusivity. Case e...

Journal of the American Veterinary Medical Association
  • Language: en
  • Pages: 942

Journal of the American Veterinary Medical Association

  • Type: Book
  • -
  • Published: 2003
  • -
  • Publisher: Unknown

Vols. for 1915-49 and 1956- include the Proceedings of the annual meeting of the association.

Official Gazette of the United States Patent Office
  • Language: en
  • Pages: 1488

Official Gazette of the United States Patent Office

  • Type: Book
  • -
  • Published: 1970
  • -
  • Publisher: Unknown

None

The Textbook of Pharmaceutical Medicine
  • Language: en
  • Pages: 883

The Textbook of Pharmaceutical Medicine

New edition of succesful standard reference book for thepharmaceutical industry and pharmaceutical physicians! The Textbook of Pharmaceutical Medicine is the coursebookfor the Diploma in Pharmaceutical Medicine, and is used as astandard reference throughout the pharmaceutical industry. The newedition includes greater coverage of good clinical practice, acompletely revised statistics chapter, and more on safety. Coversthe course information for the Diploma in PharmaceuticalMedicine Fully updated, with new authors Greater coverage of good clinical practice and safety New chapters on regulation of medical devices in Europe andregulation of therapeutic products in Australia